Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P: Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care 25:1033–1041, 2002

On page 1033 of the above-listed article, the first sentence in the results section of the abstract should read as follows:

After 1 year, the orlistat group lost significantly more weight (−3.89 ± 0.3 kg of baseline body weight, means ± SE) than the placebo group (−1.27 ± 0.3 kg, P < 0.001).